Synaptic network |
SHANK3 |
Speech-defective ASD, Phelan-McDermid syndrome, Schizophrenia |
Core ASD symptoms, Anxiety |
Hyperactive mGluR5 activity |
MPEP (mGluR5 antagonist) |
Grooming, Instrumental learning, Striatal synaptic plasticity |
Wang et al., 2016
|
|
|
|
|
|
LSD1 (H3K4me2 demethylase inhibitor) |
Core symptoms |
Rapanelli et al., 2022
|
|
|
|
|
|
Rapamycin, CLK2 inhibitor, Akt activator, IGF-1 |
Social behavior |
Bidinosti et al., 2016
|
|
|
|
|
|
Adulthood correction with SHANK3 expression |
Core symptoms |
Mei et al., 2016
|
|
|
|
|
|
IL-17a |
Social behavior |
Reed et al., 2020
|
|
CNTNAP2 (NRXN4) |
Speech-defective ASD, AR Pitt-Hopkins-like syndrom I |
Core ASD symptoms |
Projection neuron mismigration, Reduced GABAergic neurons and oxytocin neurons |
Oxytocin |
Social behavior |
Penagarikano et al., 2015
|
|
|
|
|
|
Ro27-3225 (melanocortin receptor 4 agonist) |
Social behavior |
Penagarikano et al., 2015
|
|
|
|
|
|
CX546 (positive allosteric modulator of AMPA receptor) |
Social interaction |
Sacai et al., 2020
|
|
|
|
|
|
IL-17a |
Social behavior |
Reed et al., 2020
|
|
|
|
|
|
Risperidone |
Repetitive behavior |
Penagarikano et al., 2011
|
|
NLGN3 |
GOF – X-linked ASD or Asperger syndrome |
GOF – Impaired social interaction, KO – Fragile X syndrome |
KO – Impaired corticostriatal gltamatergic synapses, E:I imbalance |
Adulthood conditional correction with WT NLGN3 in the Purkinje cells |
Synaptic plasticity |
Baudouin et al., 2012
|
|
|
|
|
|
Cannabinoid |
Synaptic plasticity |
Martella et al., 2018
|
Neuronal signaling |
PTEN |
ASD, Oncological syndromes |
Impaired social interaction |
Upregulation of the Akt-mTOR pathways, Downregulation of GSK3 |
Rapamycin (supression of mTORC1) |
Social behavior |
Zhou et al., 2009
|
|
|
|
|
|
Reduced Rictor expression (suprression of mTORC2) |
Social behavior |
Zhou et al., 2009
|
|
TSC1/TSC2 |
ASD, Tuberous sclerosis-1 |
Core ASD symptoms, Seizures |
Increased number of astrocytes, Early increase of GABAergic interneurons |
Rapamycin (supression of mTORC1) |
Seizure, Social behavior |
Zeng et al., 2008
|
|
UBE3A |
Maternal LOF – Angelman syndrome, Paternal duplication – ASD |
Double or triple dose – Core ASD symptoms |
Increased dose of UBE3A – Downregulation of glutamatergic synapse |
Cbln1 genetic expression |
Social interaction |
Krishnan et al., 2017
|
Transcriptional and Chromatin Remodeling |
CHD8 |
ASD (macrocephaly, distinct facial features, gastrointestinal motility) |
Core ASD symptoms, Abnormal brain structure, Anxiety |
Downregulation of Wnt signaling |
Genetic restoration of β-catenin |
Social behavior |
Chahrour et al., 2008
|
|
MECP2 |
ASD, Rett syndrome |
Impaired social behavior, Anxiety, Learning and memory deficit |
Impaired GABAergic neurons, Decrease of BDNF expression |
GABAA receptor agonist |
Social behavior, Anxiety, but not Memory |
Chang et al., 2006
|
|
|
|
|
|
IGF-1 |
Motor function, Breathing pattern |
Tanaka et al., 2012
|
|
|
|
|
|
BDNF |
Motor function, Electrophysiological deficits |
Hogart et al., 2007
|
|
|
|
|
|
|
|
|